Feedback

Browsing by F


Use an asterisk (*) for partial word searches (e.g. pemph*)

100 results found.

1.
Ordering Recommendation:   Predicts toxicity and responsiveness to 5-FU therapy.
2.
Ordering Recommendation:   Do not use to screen for celiac disease. May be used to estimate severity of intestinal villous atrophy in confirmed celiac disease.
3.
4.
5.
6.
Ordering Recommendation:   Evaluate for possible factor II deficiency.
7.
Ordering Recommendation:   Order to diagnose factor IX deficiency, detect factor IX inhibitors, and monitor factor IX replacement therapy.
8.
Ordering Recommendation:   Order to diagnose factor IX deficiency (hemophilia B) and monitor factor IX replacement therapy.
9.
Ordering Recommendation:   Order to detect factor V Leiden mutation.
10.
Ordering Recommendation:   Evaluate possible factor V deficiency.
11.
Ordering Recommendation:   Order to determine thrombotic risk in individuals known to be factor V Leiden heterozygotes.
12.
Ordering Recommendation:   Evaluate possible factor VII deficiency.
13.
Ordering Recommendation:   Order to diagnose factor VIII deficiency, detect factor VIII inhibitors, and monitor factor VIII replacement therapy.
14.
15.
Ordering Recommendation:   Order to diagnose hemophilia A, acquired factor VIII deficiency, or as part of a diagnostic workup for von Willebrand disease. Not recommended when screening for thrombophilia.
16.
Ordering Recommendation:   Evaluate possible factor X deficiency.
17.
Ordering Recommendation:   Order to diagnose factor XI deficiency (hemophilia C).
18.
Ordering Recommendation:   Evaluate the cause of an isolated prolonged PTT in a patient who is not currently bleeding.
19.
Ordering Recommendation:   Assess genetic risk for thrombosis.
20.
Ordering Recommendation:   First-line test to diagnose FXIII deficiency. Appropriate for evaluation of patients with a bleeding disorder present with normal PT, PTT, and platelet count test results. Use for monitoring FXIII therapy and for confirming abnormalities detected on FXIII qualitative assay.
21.
Ordering Recommendation:   Most useful for acquired or severe FXIII deficiency testing. Abnormal results should be confirmed with quantitative testing (Factor XIII Activity 2006182)
22.
23.
Ordering Recommendation:   Second line diagnostic or predictive testing for familial adenomatous polyposis. Order if APC gene sequencing was negative, or concurrently with Familial Adenomatous Polyposis (APC) Sequencing (2004863) for optimal mutation detection. Also appropriate if there is a known familial APC deletion.
24.
Ordering Recommendation:   Acceptable diagnostic or predictive testing for familial adenomatous polyposis. For classic FAP, consider concurrent APC deletion/duplication analysis (2004920).
25.
Ordering Recommendation:   Preferred diagnostic and predictive testing for familial adenomatous polyposis and MUTYH-associated polyposis.
26.
Ordering Recommendation:   Preferred test for suspected Familial Mediterranean Fever.
27.
Ordering Recommendation:   Consultation with a genetics counselor is advised. Order to detect a mutation previously identified in a family member.
28.
Ordering Recommendation:   Consultation with a genetics counselor is advised. Order for fetal testing to detect a previously characterized mutation in a family member.
29.
Ordering Recommendation:   Diagnostic testing for Fanconi anemia, group C. Carrier screening for Fanconi anemia, group C.
30.
Ordering Recommendation:   Diagnostic testing for Fanconi anemia, group C.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
Ordering Recommendation:   Confirm presence of disease; not recommended for initial testing.
41.
42.
43.
44.
45.
Ordering Recommendation:   Aids in the diagnosis of iron deficiency anemia and iron overload. Monitor treatment of hemochromatosis.
46.
47.
48.
49.
50.
Ordering Recommendation:   Diagnostic testing for FG syndrome. Carrier screening for FG syndrome.
51.
52.
Ordering Recommendation:   Recommended for the diagnosis of systemic sclerosis in patients negative for centromere, Scl-70, or RNA polymerase III antibodies.
53.
Ordering Recommendation:   This test is NOT recommended for fibrin degradation product (FDP) testing or for evaluating coagulopathies (eg, disseminated intravascular coagulation). For FDP testing, the plasma FDP test (2006491), not the serum test, is recommended. For evaluating coagulopathies, D-Dimer (0030057) is the preferred test.
54.
Ordering Recommendation:   For evaluating coagulopathies (eg, disseminated intravascular coagulation), D-Dimer (0030057) is the preferred test. If FDP testing is being considered, this plasma test, rather than the serum test, is the recommended test.
55.
Ordering Recommendation:   Determine if fibrinogen deficiency is a potential cause of bleeding.
56.
Ordering Recommendation:   A follow-up test for decreased fibrinogen activity to determine if the decrease is due to insufficient fibrinogen or dysfunctional fibrinogen.
57.
58.
59.
Ordering Recommendation:   Confirm diagnosis of ichthyosis vulgaris and differentiate vulgaris from other forms of ichthyosis.
60.
61.
62.
Ordering Recommendation:   First-line test for prognostication of CN-AML.
63.
Ordering Recommendation:   First-line test for prognostication of CN-AML. This test also provides a FTL3 mutant allelic ratio.
64.
Ordering Recommendation:   Therapeutic monitoring of fluconazole (predose or trough collection).
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
Ordering Recommendation:   Aids in detection of folate deficiency.
75.
Ordering Recommendation:   Aids in detection of folate deficiency.
76.
77.
78.
79.
80.
Ordering Recommendation:   Use in conjunction with histologic and clinical information for the diagnosis of alveolar rhabdomyosarcoma.
81.
Ordering Recommendation:   Preferred test to diagnose fragile X syndrome in individuals with characteristic clinical symptoms or screen healthy individuals for carrier status with or without a positive family history.
82.
Ordering Recommendation:   Prenatal test for fetuses of mothers with fragile X premutations or full mutations.
83.
Ordering Recommendation:   Preferred test for detecting antibodies during acute or convalescent phase. Convalescent sera may be required for diagnosis.
84.
Ordering Recommendation:   Detects antibodies during convalescent phase. Convalescent sera may be required for diagnosis.
85.
Ordering Recommendation:   Detects antibodies during acute phase; paired concurrent specimen with IgG reduces false positive rate. Convalescent sera may be required for diagnosis.
86.
Ordering Recommendation:   Direct measure of free estradiol in serum. Most accurate measure of bioactive estradiol.
87.
Ordering Recommendation:   Diagnostic testing for Freeman-Sheldon syndrome.
88.
89.
Ordering Recommendation:   May aid in monitoring glucose control for diabetes in specific disorders. Not recommended as a substitute for hemoglobin A1c except in specific populations.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.